American Journal of Transplantation

The American Journal of Transplantation is the monthly official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, founded in 2001 and published by Elsevier since January 2023, covering all major areas of organ and tissue transplantation, with a 2025 Journal Impact Factor of 8.1 and a first quartile rank of 7 of 321 in surgery《美国移植杂志》（American Journal of Transplantation）是美国移植学会与美国移植外科医师学会的官方月刊，2001 年创刊，自 2023 年 1 月起改由（Elsevier）出版，覆盖器官与组织移植的全部主要领域，2025 年影响因子为 8.1，在外科学类 321 种期刊中列第 7 位，居第一四分位。

Scope

• The journal covers thoracic transplantation of the heart and lung and abdominal transplantation of the kidney, liver, pancreas and islets, together with tissue and stem cell transplantation该刊覆盖心与肺的胸腔器官移植，以及肾、肝、胰腺与胰岛的腹部器官移植，并涵盖组织与干细胞移植。
• Organ and tissue donation and preservation form a declared subject area, taking in procurement, preservation and allocation questions器官与组织的捐献与保存是明确列出的方向，涉及获取、保存与分配等问题。
• Tissue injury, repair, inflammation and ageing are treated as core transplantation science, linking graft biology to host responses组织损伤、修复、炎症与衰老被视为移植科学的核心，把移植物生物学与宿主反应联系起来。
• Histocompatibility is within scope, as are drugs and pharmacology relevant to transplant recipients and donors组织相容性属于该刊范围，与移植受者及供者相关的药物与药理学亦在其列。
• Graft survival and the prevention of graft dysfunction and failure are central preoccupations of the journal移植物存活以及移植物功能不良与失功的预防，是该刊的核心关注点。
• Ethical and social issues in transplantation are covered, and the journal publishes original articles, case reports, invited reviews, letters, critical reviews, news features, consensus documents and guidelines across 12 issues a year移植中的伦理与社会议题也在范围之内，该刊每年 12 期，刊载原创论文、病例报告、约请综述、读者来信、评论、新闻特写、共识文件与临床指南。

History

• The journal was established in 2001 as the joint publication of the American Society of Transplantation and the American Society of Transplant Surgeons, appearing under the publisher Blackwell该刊于 2001 年创刊，由美国移植学会与美国移植外科医师学会联合主办，最初由（Blackwell）出版。
• It was set up as a forum for debate and reassessment and as an agent of change in transplantation, a framing the journal still uses on its aims page该刊创立的定位是移植领域的辩论与再评估平台、以及推动变革的力量，这一表述至今仍见于其宗旨页。
• Blackwell was taken over by Wiley in 2007, so the journal appeared as a Wiley-Blackwell title for the following decade and a half（Blackwell）于 2007 年被（Wiley）并购，此后十余年该刊以（Wiley-Blackwell）刊名出版。
• From January 2023 the journal moved to Elsevier, which publishes it for the two sponsoring societies while retaining the 12-issue monthly schedule自 2023 年 1 月起，该刊转由（Elsevier）出版，为两个主办学会出版，同时保留每年 12 期的月刊节奏。
• The journal retains the print and electronic identifiers 1600-6135 and 1600-6143 adopted in its early Blackwell years该刊沿用其早期（Blackwell）时期启用的印刷刊号 1600-6135 与电子刊号 1600-6143。
• The Journal Impact Factor moved from 8.086 in 2021 to 9.369 in 2022, 8.2 in 2024 and 8.1 in 2025, with the journal ranked second among transplantation titles该刊影响因子由 2021 年的 8.086 升至 2022 年的 9.369，2024 年为 8.2，2025 年为 8.1，在移植类期刊中位列第二。

Editors

• The journal is led by editor-in-chief Sandy Feng, a transplant surgeon and researcher at the University of California, San Francisco in the United States该刊由主编（Sandy Feng）主持，她是美国加利福尼亚大学旧金山分校的移植外科医师与研究者。
• Deputy editors and associate editors with the expertise needed for the journal's peer review process are recommended by the editor-in-chief to the Joint Council of the two societies具备该刊同行评审所需专长的副编辑与助理编辑，由主编向两个学会的联合理事会推荐任命。
• All papers, including those invited by the editorial board, are subject to peer review, and reviewer recommendations are forwarded to a deputy editor before the final decision letter is composed by the editor-in-chief所有论文（包括编委会约请稿）均须经过同行评审；审稿人意见先提交副编辑，最终决定函由主编出具。
• The editor-in-chief ordinarily prepares all decision letters and recuses from manuscripts on which he or she is an author or where a conflict of interest arises主编通常负责全部决定函，并在自身为作者或存在利益冲突的稿件上回避。
• Board members may hold financial relationships with outside entities interested in transplantation, and such relationships must be fully disclosed under the journal's conflict of interest policy编委会成员可能与移植领域相关外部机构存在财务关系，依据该刊的利益冲突政策，此类关系须完整披露。
• The journal runs an editorial fellowship programme that gives fellows and junior faculty a year-long experience of the publication and peer review process该刊设有编辑培训项目，为专科培训医师与青年教职人员提供为期一年的出版与同行评审实践机会。